Riskpilot← Back to searchSign inGet full accessPACTALAB ApS
APSActiveCVR 36409967Æblevangen 17Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20141 employees
Revenue 2024
DKK 501K
-75% vs 2023
EBITDA margin
41.4%
-39% vs 2023
Equity ratio
22.5%
Financial strength
Net profit 2024
DKK 188K
-29% vs 2023
| Revenue | DKK 501K | -75% |
| EBITDA | DKK 207K | -39% |
| Net profit | DKK 188K | -29% |
| Total assets | DKK 1M | -19% |
| Equity | DKK 229K | +41% |
| Employees | 1 | — |
Legal name
PACTALAB ApS
CVR number
36409967
Legal form
Anpartsselskab
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
15. oktober 2014
Share capital
DKK 50.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion.
Company purpose
Selskabets formål er at udvikle, producere og distribuere medicinsk udstyr samt hermed beslægtet virksomhed.
Address
Æblevangen 17
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -1.716 | 877 | -481 | -48 | 240 | 126 | 695 | 4.275 | 2.020 | 501 |
| Staff expenses | -0 | -0 | -0 | -168 | -161 | -114 | -128 | -3.019 | -1.680 | -294 |
| EBITDA | -1.716 | 877 | -481 | -217 | 79 | 12 | 567 | 1.256 | 339 | 207 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -1.716 | 877 | -481 | -217 | 79 | 12 | 567 | 1.256 | 339 | 207 |
| Net financials | -32 | -46 | 22 | -52 | -56 | 5 | 1 | -1 | 12 | 40 |
| Profit before tax | -1.748 | 831 | -459 | -268 | 24 | 17 | 568 | 1.255 | 351 | 247 |
| Tax | -384 | -198 | 582 | -0 | -0 | -0 | -0 | 250 | 86 | 59 |
| Net profit | -1.364 | 1.029 | -1.041 | -268 | 24 | 17 | 568 | 1.006 | 265 | 188 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.200 | 1.587 | 509 | 401 | 330 | 389 | 825 | 2.552 | 1.248 | 1.016 |
| Equity | -1.314 | -285 | -1.326 | -1.594 | 309 | 326 | 145 | 50 | 163 | 229 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.513 | 1.872 | 1.834 | 1.995 | 21 | 62 | 681 | 2.502 | 1.085 | 787 |
| Total debt | 2.513 | 1.872 | 1.834 | 1.995 | 21 | 62 | 681 | 2.502 | 1.085 | 787 |
EBITDA margin
41.4%
This company
15.8%
Market median
+162% vs market
20152024
Equity ratio
22.5%
This company
38.2%
Market median
-41% vs market
20152024
Return on equity
82.2%
This company
18.4%
Market median
+347% vs market
20152024
Net profit margin
37.5%
This company
8.1%
Market median
+363% vs market
20152024
Asset turnover
0.49×
This company
1.12×
Market median
-56% vs market
20152024
Debt / equity
3.44×
This company
0.62×
Market median
-455% vs market
20152024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2014-10-15 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
EV Management | Management | 2014 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2014 | — | — | |
| Chairman | 2014 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
VOGNSEN HOLDING ApS | Company | 66.7% | 66.7% | 2014 |
Bajard Invest ApS | Company | 20.0% | 20.0% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
VOGNSEN HOLDING ApS
PACTALAB ApS Board members of PACTALAB ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Esben Vognsen Jensen | Management | 0 companies |
| John Albertsen | Board of Directors | 0 companies |
| Nikolaj Vognsen Bajard | Board of Directors | 0 companies |
| Peter Clemmen Christensen | Chairman | 0 companies |